eCOA+ for better evidence generation

Better data in real time

eCOAs and digital outcome measures delivered at industry-leading speed and quality enhance your trial findings and fuel medical breakthroughs.

eCOA+ is part of Medable's unified data collection platform, which includes eConsent, telehealth, and sensors, with standardized integrations into your existing clinical ecosystem.

Medable eCOA+


Faster study build time


Pre-built and validated instruments


Available languages

Medable user holding ipad

Connected and convenient

Make data collection a breeze with devices, diaries, and sensors designed to fit into participants’ everyday lives.

Remove manual entry and configuration time with intuitive and automated workflows for sites and study teams.

Meet critical eCOA timelines

Rapidly deploy quality studies and take eCOA off the critical path of study start-up with a reusable instrument library of 300+ standardized workflows, and AI-enabled, purpose-built technology so you can work on what matters, advancing patient care.

Unlock insights with real-time data capture

Capture objective and subjective participant data in a standardized and compliant manner. Medable’s eCOA+ combines eClinROs, ePROs, ePerfOs, eObsROs, and digital measures, so you can uncover clinically meaningful insights in real-time.

Engage patients with a better experience

Medable’s eCOA+ improves inclusivity and accessibility, meeting the needs of patients in any geographic location and across diverse therapeutic areas, reducing burden and increasing retention.

The Medable difference

Reusable eCOA+ Library

Our library of 300+ reusable, pre-validated instruments, assessments and diaries ensure a standardized, consistent method of data collection that drives real-time decision making.

BYOD and provisioned devices

Accessible across web and/or mobile, provisioned devices or BYOD, unlocking patient populations that were previously out of reach while giving patients optionality.

Cross-platform TeleVisit

One seamless platform experience allows site and patient users to better engage and participate in a comfortable environment, reducing burden and increasing compliance.

Digital measures

Standardized integrations for sensors capturing digital physiological measures provide value across a variety of therapeutic areas including Oncology, Immunology, Cardiovascular, and more.

User friendy Platform

Consumer-grade UX, complete with notifications, reports, and submission-ready data, is vetted by our Patient Caregiver Network (PCN) and clinicians, ensuring accessibility.

24/7 Customer Support

Global customer care support throughout your trial for sites, patients and study teams. Our team ensure the best user experience to enable seamless technology adoption, protocol compliance, and overall user satisfaction.

Globally Compliant

Available in 60+ countries and 120+ languages, Medable’s platform is FDA, CFR21 Part 11, HIPAA, and GDPR compliant.

Powered by AI

By harnessing intelligent automation, we can reduce delivery timelines by up to 50%, enabling you to accelerate study start up and quickly capture novel endpoints.

No items found.
A top 10 pharmaceutical company approached Medable seeking support for their Phase III diabetes study in the highly competitive weight loss market. Their primary goal was to reduce the client’s average study build timelines from 16-20 weeks, down to just 8 weeks, a reduction of more than 50%.‍See how Medable was able to meet the customer's goal with this case study. ‍

A top 10 pharmaceutical company approached Medable seeking support for their Phase III diabetes study in the highly competitive weight loss market. Their primary goal was to reduce the client’s average study build timelines from 16-20 weeks, down to just 8 weeks, a reduction of more than 50%.‍See how Medable was able to meet the customer's goal with this case study. ‍

Medable platform speeds diabetes study startup by 50%

Frequently asked questions

What is eCOA?

eCOA stands for electronic clinical outcome assessment and uses electronic devices like tablets, desktop computers, and phones to collect data from trial participants. Participants complete diaries, questionnaires, or other prompts to communicate how they are feeling or functioning during the course of a clinical trial. eCOAs are part of the decentralized clinical trial (DCT) methodology and are essential to understanding whether a drug is reducing symptoms and improving patients’ quality of life.

What is Medable’s eCOA offering?

Medable’s eCOA offering is part of our broader evidence generation offering: Patient-First Data Collection.  Medable’s tools allow teams to build eCOA instruments (both validated instruments and eDiaries) that meet industry standards. Data collected from this system can be used for primary endpoints in pivotal studies. Study teams can store instruments, including translations, in a library for rapid deployment in future studies. Dashboards keep teams informed of all startup activities along the way. Teams may also access their library of prebuilt, validated instruments to improve study startup.

Does Medable’s support BYOD?

Yes. Medable's platform is multimodal, meaning patients can access our interface through the Patient app or a web browser. A BYOD model allows patients to use their own smartphone or other device for data capture during a site visit or remotely. Participants using devices they are already familiar with may lead to better compliance and ultimately, a better clinical trial experience. However, since some participants may be hesitant to download an app on their own device, or may not own a device that meets the requirements, it’s important to anticipate a percentage of provisioned devices, even in trials adopting a BYOD strategy.

The latest in eCOA

eCOA 101
Blog posts

You asked we answered: How do eCOAs improve data compliance?

6 min

We at Medable are often asked in webinars, requests for proposals (RFPs), tradeshows, etc. just how exactly eCOAs and ePROs foster better patient compliance with submitting data. 

Since you asked, our answer is below, courtesy of Jessica Dolfi, VP of Solution Consulting. 

Blog posts

Rapid evolution: How DCT’s DNA became standard in modern clinical trials

It’s impossible to deny how different clinical trials look almost four years after the pandemic revolutionized clinical research. Today, the digital and decentralized tools and technologies that enabled clinical trials to carry on through the COVID-19 pandemic are present (in some form) in nearly all clinical trials, a far cry from the dynamics of 2019.

White Papers, Case Studies, Reports

ePROs: Transforming oncology trial research

6 min

Over the last decade the number of oncology trials has skyrocketed, almost doubling the number of all other therapeutic areas combined, according to the WIRB-Copernicus Group¹. Known for their complex design, oncology trials often present various participant, site, and sponsor hurdles.

Sponsors and CROs looking to tackle these challenges andreduce the burden on participants and sites should explore the potential of digital solutions, particularly electronic informed consent (eConsent) and electronic patient reported outcomes (ePRO). Both tools offer expanded views of the participant journey while offering feedback that enables sponsors and CROs to enhance and refine their trials for all stakeholders.

See how Medable can make your trials more efficient.